RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Myocardial Protection To The Hypertrophied Heart: The Eternal Challenge [proteção Miocárdica Ao Coração Hipertrofiado: O Eterno Desafio]

The myocardial protection allowed great advance in cardiac surgery, decreasing the mortality and making more feasible complex surgeries. Latterly, the patient population elected for cardiac procedures has been changing towards elderly patients with ventricular function depressed and myocardial hypertrophy. The myocardial hypertrophy condition represents a great challenge since the beginning of the cardiac surgery. Several techniques have been described to protect the myocardial hypertrophy, however with no satisfactory results. In this manuscript we present the state of the art technique of myocardial protection.23197107Buffolo, E., História da cirurgia cardíaca brasileira, , http://publicacoes.cardiol.br/caminhos/019/default.asp, Disponível emSouza, M.H.L., Elias, D.O., (2006) Fundamentos da circulação extracorpórea, , 2a ed. Rio de Janeiro:Centro Editorial Alfa Rio;Malbouisson, L.M.S., Santos, L.M., Auler Jr, J.O.C., Carmona, M.J.C., Proteção miocárdica em cirurgia cardíaca. (2005) Rev Bras Anestesiol, 55 (5), pp. 558-574Burdette, W.J., Ashford, T.P., Structural changes in the human myocardium following hypoxia (1965) J Thorac Cardiovasc Surg, 50, pp. 210-220Bodenhamer, R.M., DeBoer, L.W., Geffin, G.A., O'Keefe, D.D., Fallon, J.T., Aretz, T.H., Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution (1983) J Thorac Cardiovasc Surg, 85 (5), pp. 769-780Jatene, A.D., Hipotermia seletiva do miocárdio. (1963) Rev Assoc Med Bras, 9, pp. 114-116Hicks, G.L., Arnold, W., DeWall, R.A., Fluorocarbon cardioplegia and myocardial protection (1983) Ann Thorac Surg, 35 (5), pp. 500-503Rashid, A., Jackson, M., Page, R.D., Desmond, M.J., Fabri, B.M., Continuous warm versus intermittent cold blood cardioplegia for coronary bypass surgery in patients with left ventricular dysfunction (1995) Eur J Cardiothorac Surg, 9 (8), pp. 405-408Tönz, M., Krogmann, O.N., Hess, O.M., Leskosek, B., Mihaljevic, T., von Segesser, L.K., Effect of intermittent warm blood cardioplegia on functional recovery after prolonged cardiac arrest (1996) Ann Thorac Surg, 62 (4), pp. 1146-1151Bouchart, F., Bessou, J.P., Tabley, A., Hecketsweiller, B., Mouton-Schleifer, D., Redonnet, M., How to protect hypertrophied myocardium? A prospective clinical trial of three preservation techniques (1997) Int J Artif Organs, 20 (8), pp. 440-446Carrier, M., Khalil, A., Tourigny, A., Solymoss, B.C., Pelletier, L.C., Metabolic recovery after global myocardial ischemia: Effects of blood cardioplegic solutions (1996) Can J Cardiol, 12 (6), pp. 607-611McCann 2nd, U.G., Lutz, C.J., Picone, A.L., Searles, B., Gatto, L.A., Dilip, K.A., La Cardioplegia con sangre total (minicardioplegia) disminuye el edema miocardico despues de lesió isquémica y derivación cardiopulmonar. (2006) J Extra Corpor Technol, 38 (1), pp. 14-21. , Mar;Robinson, L.A., Schwarz, G.D., Goddard, D.B., Fleming, W.H., Galbraith, T.A., Myocardial protection for acquired heart disease surgery: Results of a national survey (1995) Ann Thorac Surg, 59 (2), pp. 361-372Zornoff, L.A.M., Cicogna, A.C., Paiva, S.A.R., Spadaro, J., Remodelamento e seu impacto na progressão da disfunção ventricular. (2002) Rev Soc Cardiol Estado de São Paulo, 12, pp. 371-378Knobel, E., (2006) Condutas no paciente grave, pp. 17-245. , 3a ed. São Paulo:Atheneu;Abduch MCD. Avaliação dos mecanismos adaptativos do miocárdio durante sobrecarga de pressão induzida com o uso de bandagem do tronco pulmonar: participação da proliferaç ão celular [Tese de Doutorado]. São Paulo:Faculdade de Medicina da Universidade de São Paulo;2006Cicogna, A.C., Okoshi, M.P., Okoshi, K., História natural da remodelaçäo miocárdica: Da agressão aos sintomas. (2000) Rev Soc Cardiol Estado de São Paulo, 10 (1), pp. 8-16Jessup, M., Brozena, S., Heart failure (2003) N Engl J Med, 348 (20), pp. 2007-2018Barauna VG. Participação do sistema renina-angiotensina na hipertrofia cardíaca induzida pelo treinamento resistido [Dissertação de Mestrado]. São Paulo:Escola de Educação Física e Esporte da Universidade de São Paulo;2006Martins, A.S., Aguilera, N.W., Matsubara, B.B., Bregagnollo, E.A., Experimental myocardial hypertrophy induced by a minimally invasive ascending aorta coarctation (2001) Braz J Med Biol Res, 34 (3), pp. 413-415Pontes, M.R.N., Leães, P.E., Remodelamento ventricular: Dos mecanismos moleculares e celulares ao tratamento. (2004) Rev Soc Cardiol Rio Grande do Sul, 13 (3). , http://sociedades.cardiol.br/sbc-rs/revista/2004/03/artigo11.pdf, Disponível emOkoshi, M.P., Matsubara, L.S., Franco, M., Cicogna, A.C., Matsubara, B.B., Myocyte necrosis is the basis for fibrosis in renovascular hypertensive rats (1997) Braz J Med Biol Res, 30 (9), pp. 1135-1144Matsubara, L.S., Narikawa, S., Ferreira, A.L., Paiva, S.A., Zornoff, L.M., Matsubara, B.B., Remodelação miocárdica na sobrecarga crônica de pressão ou de volume no coração de ratos. (2006) Arq Bras Cardiol, 86 (2), pp. 126-130Matsubara, L.S., Matsubara, B.B., Okoshi, M.P., Cicogna, A.C., Janicki, J.S., Alterations in myocardial collagen content affect rat papillary muscle function (2000) Am J Physiol Heart Circ Physiol, 279 (4), pp. H1534-H1539Braile, D.M., Anacleto, J.C., Proteção miocárdica por cardioplegia. (1979) Arq Bras Cardiol, (SUPPL. 1), p. 19Pittella, F.J.M., (2004) Bases metabólicas do miocárdio isquêmicomiocárdio stunned, hibernado e pré-condicionamento, 1 (4). , Rio de Janeiro:Editorial Laranjeiras;Sant'Ana Jr, O., Nogueira, R.J., Murad, N., Lopes, A.C., Tucci, P.J., A depressão miocárdica pós-isquemia/reperfusão não altera a resposta cardíaca à elevação da freqüência de contrações. (2005) Arq Bras Cardiol, 84 (1), pp. 38-43Oliveira, M.A.B., Godoy, M.F., Braile, D.M., Lima-Oliveira, A.P.M., Solução cardioplégica polarizante: Estado da arte. (2005) Rev Bras Cir Cardiovasc, 20 (1), pp. 69-74Flack JE 3rd, Cook JR, May SJ, Lemeshow S, Engelman RM, Rousou JA, et al. Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation. 2000;102(19 Suppl 3):III84-9Buckeberg, G.D., Rosenkranz, E.R., Principles of cardioplegic myocardial protection (1987) Myocardial protection in cardiac surgery, pp. 71-94. , Roberts AJ, editor, New York: Marcel Dekker;Joris, I., Cuénoud, H.F., Doern, G.V., Underwood, J.M., Majno, G., Capillary leakage in inflammation. A study by vascular labeling (1990) Am J Pathol, 137 (6), pp. 1353-1363Braile, D.M., Ardito, R.V., Zaiantchick, M., Santos, J.L.V., Soares, M.J.F., Cardioplegia sanguínea contínua normotérmica. (1989) Rev Bras Cir Cardiovasc, 4 (2), pp. 109-138Steinberg, J.B., Doherty, N.E., Munfakh, N.A., Geffin, G., Titus, J.S., Hoaglin, D.C., The addition of glucose and insulin to an oxygenated cardioplegic solution (CS) (1990) J Mol Cell Cardiol, 22 (SUPPL. 5), p. 13Thorelius, J., Thelin, S., Ronquist, G., Haldén, E., Hansson, H., Creatine phosphate supplementation of cardioplegia: A clinical study (1990) J Mol Cell Cardiol, 22 (SUPPL. 5), p. 30Palomino, R.S., Benites, S.R., Montes, M.M., Soto, H.R., Roca, S.M., Ruiz, T.I., Un análisis multifactorial de ocurrencia de arritmias al despinzamiento de aorta en las cirugías electivas de revascularización miocárdica y el uso de antiarrítmicos en la reperfusión. (2007) Rev Latinoamer Tecnol Extracorp, 14 (1). , http://perfline.com/revista/volume14/v14n1/v14n1_02_art.pdf, Disponível emSouza, M.H.L., Elias, D.O., Valor prognóstico da acidose lática durante a perfusão. (2006) Rev Latinoamer Tecnol Extracorp, 13 (3). , http://perfline.com/revista, Disponível emWildenthal, K., Mierzwiak, D.S., Mitchell, J.H., Acute effects of increased serum osmolality on left ventricular performance (1969) Am J Physiol, 216 (4), pp. 898-904Dias, R.R., Dalva, M., Santos, B., Kwasnicka, K.L., Sarraff, A.P., Dias, A.R., Influência da lidocaína na proteção miocárdica com solução cardioplégica sangüínea. (2002) Rev Bras Cir Cardiovasc, 17 (3), pp. 215-220Llanes Echevarria, J.R., Batista, M., Solis, M., Suárez, A., Paredes, A., Céspedes, G., Efecto de la reperfusión sanguínea normotérmica con aporte de lidocaína-magnesio, sobre el desarrollo de fibrilación ventricular, en el período post-paro anóxico de la cirugía coronaria y valvular, con circulación extracorpórea. (2006) Rev Latinoamer Tecnol Extracorp, 13 (2), pp. 12-16Rosenkranz, E.R., Vinten-Johansen, J., Buckberg, G.D., Okamoto, F., Edwards, H., Bugyi, H., Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts, with maintenance of arrest by multidose cold blood cardioplegic infusions (1982) J Thorac Cardiovasc Surg, 84 (5), pp. 667-677Elias, D.O., Souza, M.H.L., Injúria e proteção do miocárdio em neonatos. (2004) Rev Latinoamer Tecnol Extracorp, 11 (2). , http://perfline.com/revista/volume11/v11n2/v11n2-04.html, Disponível emVinten-Johansen, J., Chiantella, V., Faust, K.B., Johnston, W.E., McCain, B.L., Hartman, M., Myocardial protection with blood cardioplegia in ischemically injured hearts: Reduction of reoxygenation injury with allopurinol (1988) Ann Thorac Surg, 45 (3), pp. 319-326Schneider, C.D., Oliveira, A.R., Radicais livres de oxigênio e exercício: Mecanismos de formação e adaptação ao treinamento físico. (2004) Rev Bras Med Esporte, 10 (4), pp. 308-313McCord, J.M., Fridovich, I., Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) (1969) J Biol Chem, 244 (22), pp. 6049-6055Lopes, A.C., (2006) Tratado de clínica médica, 2. , São Paulo:Roca;Teoh, L.K., Grant, R., Hulf, J.A., Pugsley, W.B., Yellon, D.M., A comparison between ischemic preconditioning, intermittent cross-clamp fibrillation and cold crystalloid cardioplegia for myocardial protection during coronary artery bypass graft surgery (2002) Cardiovasc Surg, 10 (3), pp. 251-255Luo, W.J., Qian, J.F., Jiang, H.H., Pretreatment with aminophylline reduces release of Troponin I and neutrophil activation in the myocardium of patients undergoing cardioplegic arrest (2007) Eur J Cardiothorac Surg, 31 (3), pp. 360-365Buckberg, G.D., A proposed "solution" to the cardioplegic controversy (1979) J Thorac Cardiovasc Surg, 77 (6), pp. 803-815Lima-Oliveira, A.P.M., Azeredo-Oliveira, M.T.V., Taboga, S.R., Godoy, M.F., Braile, D.M., Cardioplegia utilizando baixo volume de agentes cardioplégicos: Estudo morfológico em coração isolado de coelhos. (2003) Rev Bras Cir Cardiovasc, 18, pp. 227-234Cressoni, E.S., Avanci, L.E., Braile, D.M., Lima-Oliveira, A.P.M., Taboga, S.R., Martins, A.S., Efeitos das cardioplegias sangüínea e cristalóide no miocárdio hipertrófico de coelho: Avaliação estrutural e ultra-estrutural. (2007) Rev Bras Cir Cardiovasc, 22 (1), pp. 24-32Martins, A.S., Silva, M.A., Padovani, C.R., Matsubara, B.B., Braile, D.M., Catâneo, A.J., Proteção miocárdica da cardioplegia sanguínea contínua, anterógrada e retrógrada em coelhos. (2007) Acta Cir Bras, 22 (1), pp. 43-46Sobrosa, C.G., Jansson, E., Kaijser, L., Bomfim, V., Metabolismo miocárdico após cardioplegia sangüínea hipotérmica retrógrada contínua com indução anterógrada normotérmica. (2005) Rev Bras Cir Cardiovasc, 20 (4), pp. 416-422Bothe W. Retrograde administration. Multimidia manual of cardiothoracic surgery. (9 de Agosto, 2005) 809:711Bel, A., Aznag, H., Faris, B., Menasché, P., Warm blood cardioplegia in high risk patients (1997) Eur J Cardiothorac Surg, 11 (6), pp. 1118-1123Foglia, R.P., Partington, M.T., Buckberg, G.D., Leaf, J., Iatrogenic myocardial edema with crystalloid primes. Effects on left ventricular compliance, performance, and perfusion (1986) Curr Stud Hematol Blood Transfus, 53, pp. 53-63Évora, P.R., Pearson, P.J., Discigil, B., Oeltjen, M., Schaff, H.V., Efeito protetor da criocardioplegia cristalóide na isquemia global e reperfusäo durante circulaçäo extracorpórea: Um mecanismo dependente do endotélio? (1997) Rev Bras Cir Cardiovasc, 12 (1), pp. 68-76Chemnitius, J.M., Burger, W., Bing, R.J., Crystalloid and perfluorochemical perfusates in an isolated working rabbit heart preparation (1985) Am J Physiol, 249 (2 PART 2), pp. H285-H292Nappi, G., Torella, M., Romano, G., Clinical evaluation of normothermic cardiopulmonary bypass and cold cardioplegia (2002) J Cardiovasc Surg, 43 (1), pp. 31-36Martins AS. Análise comparativa entre dois métodos de proteção miocárdica: cardioplegia cristalóide, intermitente e fria e cardioplegia sanguínea, contínua tépida. Estudo experimental em coelhos [Tese de Doutorado]. Botucatu: Faculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho;1998. 170pGodoy, M.F., Braile, D.M., Cardioplegia: Exegese (1994) Arq Bras Cardiol, 62, pp. 277-278Kuznetsov, S.V., Gritsenko, V.V., Doinikov, D.N., Mochalov, O.I., Sharafutdinov, V.E., Experience in the use and comparative assessment of the effectiveness of crystalloid and blood cardioplegia (2001) Vestn Khir Im I I Grek, 160 (5), pp. 52-54Braile, D.M., Ardito, R.V., Thevenard, G.H.P., Ramin, S.L., Silva, E.M., Cardioplegia sanguínea normotérmica na revascularização cirúrgica do miocárdio. (1991) Rev Soc Cardiol Estado de São Paulo, 1, pp. 26-37Martins AS. Modelo experimental de coração suportado em coelhos: padronização e análise de variáveis hemodinâmicas, laboratoriais e anatomopatológicas [Tese de Mestrado]. Botucatu: Faculdade de Medicina de Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho;1996. 242pMartins, A.S., Matsubara, B.B., Braile, D.M., Gomes, O.M., Proteção miocárdica e função ventricular (2004) Botucatu:Cultura Acadêmica Editora, p. 262Rao, P.V., Johnson, J.M., Forsyth, A.T., A simple, safe and economical method for administration of continuous warm blood cardioplegia (1994) Perfusion, 9 (4), pp. 285-287Gomes, W.J., Ascione, R., Suleiman, M.S., Bryan, A.J., Angelini, G.D., Efeitos das cardioplegias sanguíneas hipotérmica e normotérmica nos substratos intracelulares em pacientes com corações hipertróficos. (2000) Rev Bras Cir Cardiovasc, 15 (2), pp. 160-168Godoy, M.F., Braile, D.M., Purini Neto, J., A troponina como marcador de injúria celular miocárdica. (1998) Arq Bras Cardiol, 71 (4), pp. 629-633Mair, J., Larue, C., Mair, P., Balogh, D., Calzolari, C., Puschendorf, B., Use of cardiac troponin I to diagnose perioperative myocardial infarction in coronary artery bypass grafting (1994) Clin Chem, 40 (11 PART 1), pp. 2066-2070Thormann, J., Schlepper, M., Comparison of myocardial flow, hemodynamic changes, and lactate metabolism during isoproterenol stress in patients with coronary heart disease and severe aortic stenosis (1979) Clin Cardiol, 2 (6), pp. 437-445Braile, D.M., Como eu faço: Cardioplegia sanguínea isotérmica retrógrada de baixo volume. (1992) Rev Bras Cir Cardiovasc, 7, pp. 221-229Braile DM. Cardioplegia isotérmica anterógrada retrógrada de baixo 2a ed. São José do Rio Preto;1997. p.5